84 companies

Genor Biopharma Holdings

Market Cap: HK$1.4b

A biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally.

6998

HK$2.64

7D

-1.5%

1Y

107.9%

Ocumension Therapeutics

Market Cap: HK$6.1b

Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.

1477

HK$7.53

7D

-2.2%

1Y

11.7%

CARsgen Therapeutics Holdings

Market Cap: HK$11.1b

An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors in China and the United States.

2171

HK$20.15

7D

-11.2%

1Y

183.8%

Sino Biopharmaceutical

Market Cap: HK$79.1b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

1177

HK$4.42

7D

5.0%

1Y

57.9%

China Traditional Chinese Medicine Holdings

Market Cap: HK$11.4b

China Traditional Chinese Medicine Holdings Co.

570

HK$2.26

7D

5.1%

1Y

-46.6%

Zhaoke Ophthalmology

Market Cap: HK$1.5b

An ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, and Hong Kong.

6622

HK$2.73

7D

17.2%

1Y

80.8%

JBM (Healthcare)

Market Cap: HK$2.1b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

2161

HK$2.54

7D

-1.9%

1Y

170.2%

Consun Pharmaceutical Group

Market Cap: HK$8.8b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

1681

HK$10.60

7D

6.2%

1Y

61.8%

3SBio

Market Cap: HK$46.6b

An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.

1530

HK$19.76

7D

-1.1%

1Y

217.2%

Brii Biosciences

Market Cap: HK$1.4b

Focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States.

2137

HK$1.95

7D

9.6%

1Y

65.3%

JW (Cayman) Therapeutics

Market Cap: HK$831.0m

A clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of cellular immunotherapy products in the People’s Republic of China.

2126

HK$2.05

7D

19.9%

1Y

-5.5%

Essex Bio-Technology

Market Cap: HK$3.0b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

1061

HK$5.29

7D

14.8%

1Y

104.2%

Modern Chinese Medicine Group

Market Cap: HK$228.0m

An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.

1643

HK$0.38

7D

5.6%

1Y

0%

VISEN Pharmaceuticals

Market Cap: HK$5.2b

An investment holding company, engages in the development and commercialization of endocrine therapies in the People’s Republic of China, Hong Kong, and Taiwan.

2561

HK$45.50

7D

-3.3%

1Y

n/a

Wai Yuen Tong Medicine Holdings

Market Cap: HK$399.4m

An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.

897

HK$0.35

7D

-1.4%

1Y

58.5%

WuXi Biologics (Cayman)

Market Cap: HK$104.7b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

2269

HK$25.75

7D

7.1%

1Y

129.9%

Jacobio Pharmaceuticals Group

Market Cap: HK$4.2b

An investment holding company, engages in the in-house discovery and development of oncology therapies.

1167

HK$5.37

7D

11.6%

1Y

219.6%

Antengene

Market Cap: HK$2.6b

A biopharmaceutical company, develops novel oncology therapies in Greater China and internationally.

6996

HK$3.88

7D

-0.3%

1Y

300.0%

Ascletis Pharma

Market Cap: HK$6.8b

A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.

1672

HK$7.10

7D

7.3%

1Y

482.0%

Abbisko Cayman

Market Cap: HK$5.6b

An investment holding company, engages in the research and development of pharmaceutical products in the People’s Republic of China.

2256

HK$8.93

7D

1.8%

1Y

174.8%

Kontafarma China Holdings

Market Cap: HK$178.8m

An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally.

1312

HK$0.032

7D

3.2%

1Y

-3.0%

China Health Group

Market Cap: HK$160.3m

An investment holding company, provides research and development services of drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.

8225

HK$0.16

7D

-3.6%

1Y

43.8%

China Shineway Pharmaceutical Group

Market Cap: HK$5.8b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

2877

HK$7.66

7D

2.1%

1Y

-9.7%

Jacobson Pharma

Market Cap: HK$2.6b

Through its subsidiaries, develops, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally.

2633

HK$1.30

7D

0%

1Y

120.3%

United Laboratories International Holdings

Market Cap: HK$25.4b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

3933

HK$13.96

7D

7.1%

1Y

52.6%

Simcere Pharmaceutical Group

Market Cap: HK$30.2b

Engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

2096

HK$12.20

7D

18.0%

1Y

113.7%

Dawnrays Pharmaceutical (Holdings)

Market Cap: HK$1.8b

An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.

2348

HK$1.19

7D

0%

1Y

2.6%

China Medical System Holdings

Market Cap: HK$25.6b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

867

HK$10.60

7D

16.9%

1Y

52.7%

Pak Fah Yeow International

Market Cap: HK$747.9m

An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name in Hong Kong, Macau, the People’s Republic of China, Southeast Asia, North America, the United Kingdom, and internationally.

239

HK$2.40

7D

-0.8%

1Y

-4.0%

Lee's Pharmaceutical Holdings

Market Cap: HK$877.4m

An investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China.

950

HK$1.49

7D

2.8%

1Y

20.2%

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$68.3b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

6990

HK$307.00

7D

-6.1%

1Y

89.4%

Qyuns Therapeutics

Market Cap: HK$2.5b

A clinical-stage biotech company, focuses on the research and development of biologic therapies for autoimmune and allergic diseases in the People’s Republic of China.

2509

HK$11.32

7D

-0.4%

1Y

-60.9%

HBM Holdings

Market Cap: HK$7.0b

A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel antibody therapeutics in immunology and oncology disease areas.

2142

HK$8.74

7D

-4.5%

1Y

498.6%

TOT BIOPHARM International

Market Cap: HK$1.4b

An investment holding company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in Mainland China and internationally.

1875

HK$1.84

7D

0.5%

1Y

-12.4%

Shanghai Junshi Biosciences

Market Cap: HK$32.1b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.

1877

HK$20.90

7D

23.1%

1Y

82.1%

Jilin Province Huinan Changlong Bio-pharmacy

Market Cap: HK$1.2b

Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.

8049

HK$2.12

7D

-4.1%

1Y

37.7%

Page 1 of 3